Quasi-drugs issue to trigger harsh controversy.

Published: 2006-01-04 06:56:00

Updated: 2006-01-04 06:56:00

The MOHW and KFDA recently have met with representatives from the pharmaceutical, medical and consumer group and academic experts, and indicated to run "Practical Working Council for Quasi-Drug Expansion" during January.

The Council will be responsible for the selection OTC drugs to convert t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK